Dana-Farber Cancer Institute to Retract Faulty Studies The Dana-Farber Cancer Institute, a leading cancer center affiliated with Harvard, is seeking to retract six research papers and correct dozens of others after a British scientist found flawed data in studies conducted by top executives. The faulty data, including duplicated or manipulated images, was discovered by a British molecular biologist, Sholto David, in 58 studies. This move comes amid increasing pressure on researchers to address instances of scientific misconduct and fraud. The use of new artificial intelligence tools has contributed to the identification of suspicious images in research papers. This development has raised concerns about the "publish or perish" culture in academia, which may lead to shortcuts and misleading results.